Volume 31, Issue 9 pp. 977-984
RESEARCH REPORT

An assessment of opioids on respiratory depression in children with and without obstructive sleep apnea

Adam C. Adler

Corresponding Author

Adam C. Adler

Department of Anesthesiology, Perioperative and Pain Medicine, Texas Children's Hospital, Houston, TX, USA

Baylor College of Medicine, Houston, TX, USA

Correspondence

Adam C. Adler, Department of Anesthesiology, Perioperative and Pain Medicine, Texas Children's Hospital, Baylor College of Medicine, 6621 Fannin Street, Suite #A3300, Houston TX, 77030, USA.

Email: [email protected]

Search for more papers by this author
Arvind Chandrakantan

Arvind Chandrakantan

Department of Anesthesiology, Perioperative and Pain Medicine, Texas Children's Hospital, Houston, TX, USA

Baylor College of Medicine, Houston, TX, USA

Search for more papers by this author
Brian H. Nathanson

Brian H. Nathanson

OptiStatim LLC, Longmeadow, MA, USA

Search for more papers by this author
Britta S. von Ungern-Sternberg

Britta S. von Ungern-Sternberg

Department of Anaesthesia and Pain Management, Perth Children's Hospital, Perth, WA, Australia

Division of Emergency Medicine, Anaesthesia and Pain Medicine, The University of Western Australia, Perth, WA, Australia

Telethon Kid's Institute, Perioperative Medicine Team, Perth, WA, Australia

Search for more papers by this author
First published: 30 May 2021
Citations: 1

Abstract

Background

Obstructive sleep apnea is a risk factor for respiratory depression following opioid administration as well as opioid-induced hyperalgesia. Little is known on how obstructive sleep apnea status is associated with central ventilatory depression in pediatric surgical patients given a single dose of fentanyl.

Methods

This was a single-center, prospective trial in children undergoing surgery requiring intubation and opioid administration. Sixty patients between the ages of 2–8 years presenting for surgery at Texas Children's Hospital were recruited. Twenty non-obstructive sleep apnea controls and 30 patients with moderate to severe obstructive sleep apnea met inclusion criteria. Following induction of general anesthesia and establishment of steady-state ventilation, participants received 1 mcg/kg intravenous fentanyl. Ventilatory variables (tidal volume, respiratory rate, end-tidal CO2, and minute ventilation) were assessed each minute for 10 min. The primary outcome was the extent of opioid-induced central ventilatory depression over time by obstructive sleep apnea status when compared with baseline values. Secondary aims assessed the impact of demographics and SpO2 nadir on ventilatory depression.

Results

We found no significant difference in percent decrease in respiratory rate (38.1% and 37.1%; p = .950), tidal volume (6.4% and 5.4%; p = .992), and minute ventilation (35.0 L/min and 35.0 L/min; p = .890) in control and obstructive sleep apnea patients, respectively. Both groups experienced similar percent increases in end-tidal CO2 (4.0% vs. 2.2%; p = .512) in control and obstructive sleep apnea patients, respectively.

Conclusions

In pediatric surgical patients, obstructive sleep apnea status was not associated with significant differences in central respiratory depression following a single dose of fentanyl (1 mcg/kg). These findings can help determine safe opioid doses in future pediatric obstructive sleep apneapatients.

DISCLOSURES

BvUS is a section editor for Pediatric Anesthesia. The other authors have no disclosures.

DATA AVAILABILITY STATEMENT

Raw data were generated at Texas Children's Hospital. Derived data supporting the findings of this study are available from the corresponding author on request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.